Reduced premedication (5 mg): Clinical Trials

1 trial of Reduced premedication (5 mg), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1

Follow Reduced premedication (5 mg): new trials by email Literature Review of Reduced premedication (5 mg) trials Research Report on Reduced premedication (5 mg)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer
Proactive immune tolerance induction, Standard Treatment, Paclitaxel and carboplatin - Ovarian Cancer, Endometrial Cancer
Not applicableRecruitingSeoul National University Hospital10002025-05-212026-10-07

Conditions studied

Drug Hypersensitivity (1)  ·  Endometrial Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Sponsors

Seoul National University Hospital (1)

Countries

South Korea (1)